Interestingly, higher CRP levels in the acute phase have been associated with better recovery than initial lower CRP levels (when lower levels are associated with other comorbidities, such as depression or sleep disturbances) [26]; similar findings were replicated in the 12-months outcomes of a recent prospective cohort [27]. This evidence concerns the gene CRP and depressive symptom measurement.